% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • johngunn51 johngunn51 Apr 12, 2013 11:39 AM Flag

    Peripheral neuropathy

    Look, the 59 people are very ill, God bless them, and the platinum drugs cause peripheral neuropathy by themselves. 901 works and it works at a substantially lower dose than 90mg per sq.ltr blood. These guys are very smart. If they can get a therapeutic dose in a tough setting, they will figure it out. No one in the analyst world expects 901 to succeed, 901 failure is already priced in at 17.50. If the analysts were really top notch people, they would be on the other side of the podium... This company is just at the beginning of a growth curve. If you can buy it and bank it on a crazy dip, you're smart to do so.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
13.46-0.82(-5.74%)Aug 31 4:00 PMEDT